Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ERN, PVP

Valeo Pharma Reports its 2020 Second Quarter Results and Initiates $1 Million Debenture Private Placement


MONTREAL, July 2, 2020 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) ("Valeo" or the "Company"), a Canadian specialty pharmaceutical company, today reported its financial results for the second quarter ended April 30, 2020.

"With the recent addition of Ametop and Yondelis, as well as FDA approval of Ethacrynate Sodium, the depth and diversity of our product portfolio continues to grow", said Steve Saviuk, President and Chief Executive Officer.  "Further, we expect approval of Redesca (biosimilar low molecular weight heparin ("LMWH")) in early Fall. LMWHs have long established themselves as an important class of drugs used for the prevention and treatment of blood clots. They are increasingly used to help prevent complications when novel coronavirus (COVID-19) infection is suspected".

Commenting on the second quarter 2020 results, Luc Mainville, Senior Vice-President and Chief Financial Officer said: "We continued to improve our financial performance during the second quarter. We have experienced significant increases in revenues, gross margin,  continued decrease of our net loss and EBITDA loss. The expansion of our commercial portfolio has positively impacted our results and with the launch of the above noted products this summer, we remain committed to achieve EBITDA profitability in 2020 ".

Second Quarter 2020 Financial Highlights

Year to Date 2020 Financial Results

Second Quarter 2020 Business and Product Highlights 

Second Quarter 2020 Subsequent Events

Financial Statements and MD&A

Valeo Pharma's financial statements and Management's Discussion and Analysis for the three-month and six-month periods ended April 30, 2020 are available on SEDAR at www.sedar.com

About Valeo Pharma

Valeo Pharma is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada. With a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products, Valeo Pharma has a growing portfolio of innovative products and the full infrastructure to properly manage these products through all stages of commercialization. Headquartered in Kirkland, Quebec, Valeo Pharma has all capabilities internally to register and market health care solutions for Canadian patients. For more information, please visit http://www.valeopharma.com and follow us on LinkedIn and Twitter.

Forward-Looking Statements

This news release may contain certain forward-looking statements regarding the Company's expectations for future events. Such expectations are based on certain assumptions that are founded on currently available information. If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this press release. Factors that could cause actual results to differ include, amongst others, uncertainty as to the final result and other risks. The Company disclaims any intention or obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise, other than as required by security laws.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE Valeo Pharma inc.


These press releases may also interest you

at 21:36
Aliansce Sonae Shopping Centers S.A. , one of the largest shopping mall owners and operators in Brazil, announces its results for the second quarter of 2020 (2Q20). 2Q20 Highlights: 98% of the portfolio's GLA opened. The reopening process of Aliansce...

at 21:20
Cogobuy Group ("Cogobuy" or the "Company", stock code: 400.HK; with its subsidiaries (the ''Group'')) is pleased to announce the Company's flagship  Ingdan Innovations, a platform engaged in chip sales and technology services, has signed a strategic...

at 21:09
In the news release, Market Share Expanded to 21.5% Volume Grew 47.9% to 4.6 Billion Parcels, issued 12-Aug-2020 by ZTO Express (Cayman) Inc. over PR Newswire, we are advised by the company that the [5th] paragraph, [2nd] sentence, should read "[We...

at 21:03
Today, DLP Real Estate Capital is proud to announce that it has made the 2020 Inc. 5000 List of the Fastest-Growing Private Companies in America, landing as the 4th fastest growing company in the nation out of those who have made the list 8 or more...

at 21:00
Once the consumer finds the vehicle, ShopSmartAutos.com's integration with Cox brand Dealertrack's Finance Driver allows the consumer to submit an online credit application from the vehicle listing, which helps set realistic expectations for both...

at 20:29
Mediagrif Interactive Technologies Inc. , a leader in SaaS digital commerce technologies, today released its financial results3 for the first quarter of fiscal 2021 which ended on June 30, 2020. All dollar amounts are expressed in Canadian currency...



News published on 2 july 2020 at 07:00 and distributed by: